Security file · CUSIP 46625H100
JPM
JPMORGAN CHASE & CO · US listing · held by 13 tracked managers in Q3 2026.
Tracked holders · Q3 2026
13
-3 vs Q2 2026
Aggregate reported value
$756M
sum of holders' reported positions
New holders this quarter
0
1 added · 8 trimmed
Holder return since filing
+1.2%
weighted by each holder's position share · since filing
Ownership · Q3 2026
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Mairs & Power Fundsfiled 16 Nov ET | 2.68% | 882K | -4.5% | $341 | +0.0% | $292M | Trimmed |
| 2 | Christopher Davis - Davis Advisorsfiled 10 Nov ET | 0.67% | 471K | -1.0% | $342 | -0.3% | $156M | Trimmed |
| 3 | Richard Pzena - Pzena Investment Managementfiled 30 Oct ET | 0.33% | 341K | +2.1% | $337 | +1.2% | $113M | Added |
| 4 | Thomas Gayner - Markel Groupfiled 30 Oct ET | 0.65% | 253K | +0.0% | $337 | +1.2% | $83.55M | Held |
| 5 | David Katz - Matrix Asset Advisorsfiled 13 Oct ET | 3.52% | 129K | -2.8% | $331 | +2.9% | $42.75M | Trimmed |
| 6 | Dodge & Cox Fundsfiled 13 Nov ET | 0.02% | 111K | -4.9% | $346 | -1.5% | $36.85M | Trimmed |
| 7 | Francois Rochon - Giverny Capitalfiled 12 Nov ET | 0.54% | 47K | -1.4% | $343 | -0.5% | $15.62M | Trimmed |
| 8 | Samantha McLemore - Patient Capital Managementfiled 12 Nov ET | 0.31% | 29K | -0.0% | $343 | -0.5% | $9.71M | Held |
| 9 | Thomas Russo - Gardner Russo & Quinnfiled 12 Nov ET | 0.03% | 8,610 | -65.2% | $343 | -0.5% | $2.85M | Trimmed |
| 10 | Glenn Greenberg - Brave Warrior Advisorsfiled 16 Nov ET | 0.04% | 5,643 | +0.0% | $341 | +0.0% | $1.87M | Held |
| 11 | Torray Fundsfiled 29 Oct ET | 0.13% | 2,959 | +0.0% | $337 | +1.2% | $979K | Held |
| 12 | Kahn Brothers Groupfiled 16 Nov ET | 0.16% | 2,868 | -0.3% | $341 | +0.0% | $949K | Trimmed |
| 13 | Greenhaven Associatesfiled 26 Oct ET | 0.00% | 1,000 | -60.0% | $334 | +2.1% | $331K | Trimmed |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q3 2026 | 13 | -3 | $756M | 2.29M |
| Q2 2026 | 16 | +2 | $1.72B | 5.26M |
| Q1 2026 | 14 | +0 | $1.55B | 5.28M |
| Q4 2025 | 14 | +1 | $1.68B | 5.21M |
| Q3 2025 | 13 | -1 | $2.24B | 7.09M |
| Q2 2025 | 14 | +0 | $2.19B | 7.57M |
| Q1 2025 | 14 | +1 | $1.62B | 6.59M |
| Q4 2024 | 13 | +6 | $2.60B | 10.85M |
| Q3 2024 | 7 | +1 | $1.25B | 5.92M |
| Q2 2024 | 6 | -1 | $484M | 2.39M |
| Q1 2024 | 7 | +0 | $1.38B | 6.87M |
| Q4 2023 | 7 | -2 | $1.89B | 11.12M |
| Q3 2023 | 9 | +2 | $1.68B | 11.58M |
| Q2 2023 | 7 | +5 | $1.06B | 7.30M |
| Q1 2023 | 2 | — | $276M | 2.12M |